Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > You think?

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon May 17, 2023 3:08am

144 Views

Post# 35451718

RE:RE:You think?

@Slayer, someone previously pointed out that Sigma Aldrich is owned by a different entity not associated with the Merck Pharma we know. It is still owned by the original Merck Group. The US Merck we know split from the original. Just wanted to point that out. In any case, the business case for acquiring TLT doesn't change

<< Previous

Bullboard Posts

Next >>

Junior helium stock to benefit from new legislation in U.S.